We are monitoring the impact of COVID-19 & Recession alarm on APAC Plasma Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Plasma Protein Therapeutics Market Research Report – Segmented By Product Type, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 208
Pages: 140

APAC Plasma Protein Therapeutics Market Size (2022 to 2027)

The size of the plasma protein therapeutics market in the Asia Pacific is currently estimated at USD 5477.43 Million in 2022. It is further forecasted to reach USD 9494.70 Million by 2027, growing at a significant CAGR of 11.63% during the forecast period.

The number of blood donations is rapidly growing year-over-year in the APAC region, which is estimated to favor this region's plasma protein therapeutics market. Many awareness camps are helping people to understand the importance of blood donations. In addition, there are many new technological advancements in the plasma protein therapeutics market, such as introducing the new and less costly method to separate protein from plasma, increasing the demand for the APAC plasma protein therapeutics market significantly.

New types of plasma therapies deal with infectious diseases such as Rabies, Tetanus, Hepatitis A&B, and varicella much effectively. With the increase in the number of diseases like these, the market is expected to grow rapidly. Therefore, these new plasma protein therapies are increasing the demand for the APAC plasma protein therapeutics market.

The plasma proteins are started to produce new opportunities in the pharmaceutical market, and they are helping the treatment of various diseases such as hemostasis. Many new treatment methods are being introduced with the help of plasma proteins, increasing the efficiency of the result and helping the growth of the APAC plasma protein therapeutics market. With the help of plasma protein, people can find out about diseases like genetic disorder diseases in the starting stages, which helps treat the disease. This increases the demand for the plasma protein therapeutics market. Furthermore, as the use of targeted therapies is growing worldwide, a new type of therapy is being introduced to increase the effectiveness of the treatment according to the conditions of each patient. This is increasing the growth of the Plasma Protein Therapeutics Market. Plasma proteins are vital for the desired outcome of the treatment with these new therapy treatments. 

However, strict government rules are one of the significant drawbacks of the APAC plasma protein therapeutics market. In addition, the complex process of manufacturing and using is hampering the growth of the market.

This research report on the Asia Pacific plasma protein therapeutics market has been segmented and sub-segmented into the following categories:

By Type: 

  • Immunoglobulins
  • Albumin
  • Coagulation Factor
  • Alpha-1 Proteinase Inhibitor
  • Others

By Application: 

  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency
  • Others

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

During the forecast period, the APAC market is expected to project the fastest growth rate among all the regions in the global market. This is because the applications of plasma proteins are increasing in the pharmaceutical sector. In addition, a new method of separating protein from the plasma can be done with low cost and outstanding efficiency. These recent technological advancements are expected to drive the market in the coming years.

With new therapy methods, the growth of the Plasma Protein Therapeutics Market is increasing in the Asia Pacific. These are mainly dominating in China and India because of government support and high awareness among the people. These are the main factors that will help the growth of the market rapidly in the coming years.

In the plasma protein market of Asia Pacific, with an increasing population and rising demand for advanced therapeutics, China is expected to have the highest share. With this rising demand, Chinese industry key players are interested in the APAC Plasma Protein Therapeutics Market.

KEY MARKET PLAYERS:

Companies dominating the APAC Plasma Protein Therapeutics Market profiled in this report are Grifols, CSL Behring, Baxter, Krdrion, China Biologics, Octapharma, Chendu Inst, and Shire Plc.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 others                                                       

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                6.2 China                                                                             

                6.3 India                                                                              

                6.4 Japan                                                                            

                6.5 South Korea                                                                               

                6.6 Australia                                                                      

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  1. Asia-Pacific Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  3. Asia-Pacific Immunoglobulins Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific Albumin Market, By Region, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Coagulation Factors Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Alpha-1 proteinase inhibitor Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia-Pacific Others Market, By Region, From 2022 - 2027 (USD Million)
  8. Asia-Pacific Hemophilia Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia-Pacific Primary Immunodeficiency Disorder Market, By Region, From 2022 - 2027 (USD Million)
  10. Asia-Pacific Idiopathic Thrombocytopenic Purpura Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific Secondary Immunodeficiency Market, By Region, From 2022 - 2027 (USD Million)
  12. Asia-Pacific Others Market, By Region, From 2022 - 2027 (USD Million)
  13. China Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  14. India Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  15. Japan Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  16. South Korea Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  17. Australia Plasma Protein Therapeutics Market, By Type, From 2022 - 2027 (USD Million)
  18. China Plasma Protein Therapeutics Market, By Application From 2022 - 2027 (USD Million)
  19. India Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  20. Japan Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  21. South Korea Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  22. Australia Plasma Protein Therapeutics Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample